Dexlansoprazole
- TRADE NAME: Dexilant (Takeda)
- INDICATIONS: Erosive esophagitis, heartburn associated with gastroesophageal reflux disease
- CLASS: Proton pump inhibitor (PPI)
- HALF-LIFE: <2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Atazanavir, Clopidogrel, Digoxin, Emtricitabine/Rilpivirine/Tenofovir Alafenamide, Ketoconazole, Tacrolimus, Warfarin
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 01/31/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric